<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000600465"><TermName>Relistor</TermName><TermPronunciation>(REH-lih-stor)</TermPronunciation><TermDefinition><DefinitionText>A drug used to relieve certain side effects caused by treatment with opiods (pain killers similar to morphine), such as constipation (hard, dry stools), itching, and low urine flow. Relistor binds to opioid receptors outside the brain and may block the side effects of opioid drugs without affecting their ability to relieve pain. Relistor is a type of peripheral opioid receptor antagonist. Also called methylnaltrexone bromide.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720629" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Relistor&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720628" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Relistor&quot;" language="es" id="_4"/><SpanishTermName>Relistor</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para aliviar ciertos efectos secundarios del tratamiento con opioides (analgésicos similares a la morfina); por ejemplo, el estreñimiento (heces duras y secas), la picazón y el flujo escaso de orina. El Relistor se une a los receptores opioides fuera del cerebro y puede bloquear los efectos secundarios de los opioides sin afectar su capacidad de aliviar el dolor. El Relistor es un tipo de antagonista del receptor periférico de opioides. También se llama bromuro de metilnaltrexona.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-07-18</DateFirstPublished></GlossaryTerm>
